Pharmacokinetics and safety of glecaprevir and pibrentasvir in HCV-negative subjects with hepatic impairment
暂无分享,去创建一个
R. Preston | E. Gane | J. Kort | T. Marbury | F. Mensa | E. Lawitz | D. Pugatch | Haoyu Wang | M. Kosloski | Wei Liu | Matthew P. Kosloski